154 related articles for article (PubMed ID: 30809981)
21. [The features and significance of immunophenotyping in adult acute leukemia].
Pei MF; Zhang GS; Xiao L
Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):262-4. PubMed ID: 12212161
[TBL] [Abstract][Full Text] [Related]
22. Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.
Ommen HB; Schnittger S; Jovanovic JV; Ommen IB; Hasle H; Østergaard M; Grimwade D; Hokland P
Blood; 2010 Jan; 115(2):198-205. PubMed ID: 19901261
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia.
Kim TJ; Park SH
J Korean Med Sci; 1998 Oct; 13(5):455-8. PubMed ID: 9811172
[TBL] [Abstract][Full Text] [Related]
25. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
27. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
28. Immunophenotyping pediatric leukemias in Kelantan, Malaysia.
Menon BS; Dasgupta A; Jackson N
Pediatr Hematol Oncol; 1998; 15(2):175-8. PubMed ID: 9592844
[TBL] [Abstract][Full Text] [Related]
29. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
30. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
31. A cell surface molecule, JL1; a specific target for diagnosis and treatment of leukemias.
Park WS; Bae YM; Chung DH; Kim TJ; Choi EY; Chung JK; Lee MC; Park SY; Park MH; Park SH
Leukemia; 1998 Oct; 12(10):1583-90. PubMed ID: 9766503
[TBL] [Abstract][Full Text] [Related]
32. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract][Full Text] [Related]
33. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
[TBL] [Abstract][Full Text] [Related]
34. [Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype].
Liu YR; Lai YY; Chang Y; Ruan GR; Qin YZ; Wang YZ; Zhu HH; Shi HX; Jiang B; Jiang H; Jiang Q; Hao L; Li JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1385-9. PubMed ID: 24370016
[TBL] [Abstract][Full Text] [Related]
35. Incidence and prognostic importance of molecular genetic defects in children with acute myeloblastic leukemia.
Kömür M; Erbey F; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(5):1393-5. PubMed ID: 21198299
[TBL] [Abstract][Full Text] [Related]
36. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
37. Incidence of preleukemic fusion genes in healthy subjects.
Kosik P; Skorvaga M; Belyaev I
Neoplasma; 2016; 63(5):659-72. PubMed ID: 27468869
[TBL] [Abstract][Full Text] [Related]
38. Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.
Metzeler KH; Bloomfield CD
Adv Exp Med Biol; 2017; 962():175-199. PubMed ID: 28299658
[TBL] [Abstract][Full Text] [Related]
39. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
